BR112013008638A2 - inibidores de oxadiazol de produção de leucotrieno - Google Patents
inibidores de oxadiazol de produção de leucotrienoInfo
- Publication number
- BR112013008638A2 BR112013008638A2 BR112013008638A BR112013008638A BR112013008638A2 BR 112013008638 A2 BR112013008638 A2 BR 112013008638A2 BR 112013008638 A BR112013008638 A BR 112013008638A BR 112013008638 A BR112013008638 A BR 112013008638A BR 112013008638 A2 BR112013008638 A2 BR 112013008638A2
- Authority
- BR
- Brazil
- Prior art keywords
- leukotriene production
- oxadiazole
- inhibitors
- oxadiazole inhibitors
- leukotriene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38573310P | 2010-09-23 | 2010-09-23 | |
| US201161533349P | 2011-09-12 | 2011-09-12 | |
| PCT/US2011/052254 WO2012040139A1 (en) | 2010-09-23 | 2011-09-20 | Oxadiazole inhibitors of leukotriene production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112013008638A2 true BR112013008638A2 (pt) | 2016-06-21 |
Family
ID=44720163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013008638A BR112013008638A2 (pt) | 2010-09-23 | 2011-09-20 | inibidores de oxadiazol de produção de leucotrieno |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8575201B2 (pt) |
| EP (1) | EP2619197B1 (pt) |
| JP (1) | JP5713511B2 (pt) |
| KR (1) | KR20130109122A (pt) |
| CN (1) | CN103261193A (pt) |
| AU (1) | AU2011305667A1 (pt) |
| BR (1) | BR112013008638A2 (pt) |
| CA (1) | CA2812449A1 (pt) |
| CL (1) | CL2013000788A1 (pt) |
| CO (1) | CO6710902A2 (pt) |
| EA (1) | EA201300389A1 (pt) |
| EC (1) | ECSP13012548A (pt) |
| IN (1) | IN2013DN02555A (pt) |
| MX (1) | MX2013003202A (pt) |
| PE (1) | PE20131398A1 (pt) |
| SG (1) | SG188604A1 (pt) |
| WO (1) | WO2012040139A1 (pt) |
| ZA (1) | ZA201301747B (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5862669B2 (ja) * | 2010-08-26 | 2016-02-16 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ロイコトリエン産生のオキサジアゾール阻害剤 |
| US8575201B2 (en) | 2010-09-23 | 2013-11-05 | Boehringer Ingelheim International Gmbh | Oxadiazole inhibitors of leukotriene production |
| WO2012040137A1 (en) * | 2010-09-23 | 2012-03-29 | Boehringer Ingelheim International Gmbh | Oxadiazole inhibitors of leukotriene production |
| AR089853A1 (es) | 2012-02-01 | 2014-09-24 | Boehringer Ingelheim Int | Inhibidores de oxadiazol de la produccion de leucotrienos para terapia de combinacion, composicion farmaceutica, uso |
| EP2951170B1 (en) * | 2013-02-04 | 2018-10-24 | Janssen Pharmaceutica NV | Flap modulators |
| PL2875736T3 (pl) | 2013-11-26 | 2017-02-28 | Citrage | N-karbamoiloputrescyna do zwiększenia syntezy białka mięśni |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EE200200057A (et) | 1999-08-06 | 2003-04-15 | Janssen Pharmaceutica N.V. | Kasvutegurit IL-5 pärssiv asauratsiilderivaat, selle saamine ja kasutamine ravimi valmistamiseks ning seda sisaldav farmatseutiline kompositsioon |
| CA2528805A1 (en) * | 2003-08-13 | 2005-05-06 | Chiron Corporation | Gsk-3 inhibitors and uses thereof |
| US7319108B2 (en) | 2004-01-25 | 2008-01-15 | Sanofi-Aventis Deutschland Gmbh | Aryl-substituted heterocycles, process for their preparation and their use as medicaments |
| JP2008516968A (ja) | 2004-10-18 | 2008-05-22 | メルク エンド カムパニー インコーポレーテッド | ジフェニル置換アルカン類 |
| US8399666B2 (en) * | 2005-11-04 | 2013-03-19 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
| GB2431927B (en) | 2005-11-04 | 2010-03-17 | Amira Pharmaceuticals Inc | 5-Lipoxygenase-activating protein (FLAP) inhibitors |
| US7977359B2 (en) | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
| WO2007120574A2 (en) | 2006-04-11 | 2007-10-25 | Merck & Co., Inc. | Diaryl substituted alkanes |
| ES2376396T3 (es) | 2006-06-26 | 2012-03-13 | Amgen Inc. | Método para tratar aterosclerosis. |
| WO2008030369A1 (en) * | 2006-09-01 | 2008-03-13 | Merck & Co., Inc. | Inhibitors of 5 -lipoxygenase activating protein ( flap) |
| AU2008241313A1 (en) | 2007-04-20 | 2008-10-30 | Merck Frosst Canada Ltd. | Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| WO2008156721A1 (en) | 2007-06-20 | 2008-12-24 | Merck & Co., Inc. | Diphenyl substituted alkanes |
| US20110003815A1 (en) | 2007-10-10 | 2011-01-06 | Merck & Co., Inc. | Diphenyl substituted cycloalkanes |
| DE102008037790A1 (de) * | 2008-08-14 | 2010-02-18 | Merck Patent Gmbh | Bicyclische Triazolderivate |
| US8598209B2 (en) * | 2008-10-31 | 2013-12-03 | Merck Sharp & Dohme Corp. | P2X3, receptor antagonists for treatment of pain |
| JP2012516885A (ja) | 2009-02-04 | 2012-07-26 | ファイザー・インク | ４−アミノ−７，８−ジヒドロピリド［４，３−ｄ］ピリミジン−５（６Ｈ）−オン誘導体 |
| SG185414A1 (en) | 2010-05-12 | 2012-12-28 | Univ Vanderbilt | Heterocyclic sulfone mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| PE20130751A1 (es) * | 2010-08-16 | 2013-06-21 | Boehringer Ingelheim Int | Inhibidores de oxadiazol de la produccion de leucotrieno |
| JP5862669B2 (ja) * | 2010-08-26 | 2016-02-16 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ロイコトリエン産生のオキサジアゾール阻害剤 |
| WO2012040137A1 (en) * | 2010-09-23 | 2012-03-29 | Boehringer Ingelheim International Gmbh | Oxadiazole inhibitors of leukotriene production |
| US8575201B2 (en) | 2010-09-23 | 2013-11-05 | Boehringer Ingelheim International Gmbh | Oxadiazole inhibitors of leukotriene production |
-
2011
- 2011-09-20 US US13/237,112 patent/US8575201B2/en active Active
- 2011-09-20 EP EP11761775.3A patent/EP2619197B1/en active Active
- 2011-09-20 PE PE2013000629A patent/PE20131398A1/es not_active Application Discontinuation
- 2011-09-20 SG SG2013020300A patent/SG188604A1/en unknown
- 2011-09-20 WO PCT/US2011/052254 patent/WO2012040139A1/en active Application Filing
- 2011-09-20 IN IN2555DEN2013 patent/IN2013DN02555A/en unknown
- 2011-09-20 BR BR112013008638A patent/BR112013008638A2/pt not_active IP Right Cessation
- 2011-09-20 JP JP2013530221A patent/JP5713511B2/ja active Active
- 2011-09-20 EA EA201300389A patent/EA201300389A1/ru unknown
- 2011-09-20 CN CN2011800565586A patent/CN103261193A/zh active Pending
- 2011-09-20 CA CA2812449A patent/CA2812449A1/en not_active Abandoned
- 2011-09-20 MX MX2013003202A patent/MX2013003202A/es active IP Right Grant
- 2011-09-20 AU AU2011305667A patent/AU2011305667A1/en not_active Abandoned
- 2011-09-20 KR KR1020137007287A patent/KR20130109122A/ko not_active Application Discontinuation
-
2013
- 2013-03-07 ZA ZA2013/01747A patent/ZA201301747B/en unknown
- 2013-03-21 CL CL2013000788A patent/CL2013000788A1/es unknown
- 2013-03-22 CO CO13057875A patent/CO6710902A2/es not_active Application Discontinuation
- 2013-04-11 EC ECSP13012548 patent/ECSP13012548A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201300389A1 (ru) | 2013-09-30 |
| ZA201301747B (en) | 2014-08-27 |
| CN103261193A (zh) | 2013-08-21 |
| WO2012040139A1 (en) | 2012-03-29 |
| MX2013003202A (es) | 2013-04-24 |
| US20120295896A1 (en) | 2012-11-22 |
| ECSP13012548A (es) | 2013-06-28 |
| IN2013DN02555A (pt) | 2015-08-07 |
| CL2013000788A1 (es) | 2013-06-28 |
| JP2013537909A (ja) | 2013-10-07 |
| AU2011305667A1 (en) | 2013-03-21 |
| CO6710902A2 (es) | 2013-07-15 |
| JP5713511B2 (ja) | 2015-05-07 |
| US8575201B2 (en) | 2013-11-05 |
| EP2619197B1 (en) | 2015-08-05 |
| CA2812449A1 (en) | 2012-03-29 |
| EP2619197A1 (en) | 2013-07-31 |
| PE20131398A1 (es) | 2013-12-19 |
| SG188604A1 (en) | 2013-04-30 |
| KR20130109122A (ko) | 2013-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL259958B (en) | Heterocyclic glutaminase inhibitors | |
| ZA201300238B (en) | Oxadiazole inhibitors of leukotriene production | |
| SMT201600311B (it) | Inibitori di cdk | |
| SMT201600135B (it) | Nuovi inibitori della s-nitrosoglutatione riduttasi | |
| AP3339A (en) | Benzodioxane inhibitors of leukotriene production | |
| SMT201500271B (it) | Inibitori di neprilisina | |
| ZA201309561B (en) | Novel inhibitor compounds of phosphodiestarase type 10a | |
| HK1177205A1 (en) | Oxazole kinase inhibitors | |
| DK3178818T3 (da) | Pyrazolylquinoxalinkinasehæmmere | |
| HK1243175A1 (zh) | 標記的hsp90抑製劑的用途 | |
| DK2371923T3 (da) | Aflejringshæmmer | |
| SMT201600001B (it) | Imidazopiridazine come inibitori di akt chinasi | |
| BRPI1013422A2 (pt) | derivados de oxadiazol | |
| ZA201206456B (en) | Uses of dgati inhibitors | |
| SMT201600031B (it) | Composti eterociclici di fenossimetile | |
| DK2506840T3 (da) | Anvendelser af hæmmere af hypoksi-fremkaldende faktorer | |
| BR112013008638A2 (pt) | inibidores de oxadiazol de produção de leucotrieno | |
| SMT201700085B (it) | Forma cristallina di pemirolast | |
| FI20105638A0 (fi) | Kivipinnoitteen valmistus | |
| AP2013006762A0 (en) | Oxadiazole inhibitors of leukotriene production | |
| IT1400965B1 (it) | Polimorfi di fexofenadina | |
| UA21042S (uk) | Комплект бланків | |
| NO20111283A1 (no) | Regassifisering av LNG med Rankinkrets | |
| IT1403340B1 (it) | Mezzi di trasferimento | |
| UA22461S (uk) | Деталь фасонна компресійна-цанга |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |